Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118372374 | 11837237 | 4 | F | 2015 | 20160620 | 20151215 | 20160708 | PER | US-PFIZER INC-2015421506 | PFIZER | 78.00 | YR | F | Y | 73.00000 | KG | 20160708 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118372374 | 11837237 | 1 | PS | LYRICA | PREGABALIN | 1 | 150 MG, 3X/DAY | Y | U | 21446 | 150 | MG | TID | ||||||
| 118372374 | 11837237 | 2 | SS | LYRICA | PREGABALIN | 1 | 300 MG, 2X/DAY, IN THE MORNING AND AT NIGHT | Y | U | 21446 | 300 | MG | BID | ||||||
| 118372374 | 11837237 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 IN THE MORNING AND AFTERNOON, 300MG AT NIGHT | Y | U | 21446 | 600 | MG | ||||||
| 118372374 | 11837237 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 150 IN THE MORNING AND AFTERNOON, 300MG AT NIGHT | Y | U | M22817 | 21446 | 600 | MG | |||||
| 118372374 | 11837237 | 5 | C | ALEVE | NAPROXEN SODIUM | 1 | ONE IN THE MORNING AND ONE IN THE AFTERNOON | 0 | 1 | DF | BID | ||||||||
| 118372374 | 11837237 | 6 | C | PROPRANOLOL | PROPRANOLOLPROPRANOLOL HYDROCHLORIDE | 1 | Oral | 60 MG, 1X/DAY | 0 | 60 | MG | TABLET | QD | ||||||
| 118372374 | 11837237 | 7 | C | THYROID | LEVOTHYROXINELIOTHYRONINE | 1 | UNK | 0 | |||||||||||
| 118372374 | 11837237 | 8 | C | Calcium Caltrate with Vitamin D | 2 | Oral | 2 DF, DAILY | 0 | 2 | DF | TABLET | ||||||||
| 118372374 | 11837237 | 9 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 300 MG, 1X/DAY | 0 | 300 | MG | TABLET | QD | ||||||
| 118372374 | 11837237 | 10 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 300 MG, 3X/DAY | U | 0 | 300 | MG | CAPSULE | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118372374 | 11837237 | 1 | Neuralgia |
| 118372374 | 11837237 | 2 | Neck pain |
| 118372374 | 11837237 | 3 | Pain in extremity |
| 118372374 | 11837237 | 5 | Pain |
| 118372374 | 11837237 | 6 | Tremor |
| 118372374 | 11837237 | 8 | Blood calcium abnormal |
| 118372374 | 11837237 | 9 | Gout |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118372374 | 11837237 | Drug ineffective | |
| 118372374 | 11837237 | Fatigue | |
| 118372374 | 11837237 | Hypoaesthesia | |
| 118372374 | 11837237 | Pain | |
| 118372374 | 11837237 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118372374 | 11837237 | 1 | 2011 | 0 | ||
| 118372374 | 11837237 | 4 | 20160424 | 0 | ||
| 118372374 | 11837237 | 8 | 201511 | 0 | ||
| 118372374 | 11837237 | 9 | 2014 | 0 | ||
| 118372374 | 11837237 | 10 | 20160422 | 0 |